Servier China

Wherever Innovation Leads, Patients Come First. 💙   In a recent interview with the China Economic Observer, Olivier Laureau, the President of Servier, shared his vision of our unwavering dedication to patients and innovation. This conversation goes beyond strategy—it is about our vocation and the impact we strive to make every day: •   Committed to Therapeutic Progress: As a group governed by a non-profit foundation, we are solely focused on patients. This position allows us to invest in long-term innovation dedicated to the health of future generations. •   Accelerating Innovation: We don't just wait for the future; we build it. By integrating AI and data into our everyday duty, we are accelerating the discovery of innovative solutions to address unmet medical needs today. •   A Strategic Partnership with China: Our history in China is a testament to our shared mission. We see China as a global engine for innovation, playing a pivotal role in our strategy to enhance patient access and drive healthcare progress worldwide. •   Focused on Life-Changing Areas: While maintaining our leadership in cardiovascular and metabolic diseases, we are becoming a leader in oncology and neurology. We are "Moved by You"—inspired by the courage of patients to push the boundaries of science. Innovation is a journey we take together. 📺We invite you to watch the highlights of the interview to see how Servier is bridging science and heart to create a healthier world. 全球创新，为患者而来 💙   近期，集团总裁Olivier Laureau在中国接受《经济观察报》采访时，分享了施维雅对中国的长期承诺以及对患者和创新的坚定奉献。这次对话不只是战略层面，更彰显了我们的使命，以及我们每天努力所创造的影响： •   致力于治疗进展：作为一个由非营利基金会管理的制药集团，我们完全专注于患者。这一独特定位使我们能够投资于长期创新，致力于人类健康。 •   加速创新：我们并不等待未来，而是创造未来。通过将人工智能和数据融入每日工作，我们正在加速发现创新解决方案，以满足当今未被满足的医疗需求。 •   与中国建立战略伙伴关系：我们在中国的深耕见证了我们共同的使命。中国是集团的全球创新引擎，在提升患者可及性、推动全球医疗进步的战略中发挥着关键作用。 •   聚焦改变生命的疾病领域：在保持心血管及代谢性疾病领域领导地位的同时，我们正成为肿瘤学和神经学领域的领先者。我们受患者勇气的启发，不断突破科学边界。   我们正在携手共同创新。 📺邀请您观看专访的精彩片段，了解施维雅如何将科学与人文关怀相融合，共同创造更健康的世界。   #Servier #MovedByYou #PatientCentricity #Innovation #ServierChina #Oncology #Neurology #RareDiseases

💙Innovation powers our future in China. We are operating in an era of unprecedented opportunity—a gateway that allows us to deliver life-changing breakthroughs to the patients who need them most. Earlier this week, #ServierChina had the honor of welcoming our President, Olivier Laureau, and the Executive Committee. Together, we engaged in deep strategic dialogues focused on our mission to redefine healthcare through breakthrough innovative drugs and strategic partnerships to permanently answer patients medical needs. Key takeaways from the visit: 🔹 China as a Global Engine in Innovation: Reaffirming China’s role as a vital pillar of our #Servier2030 ambition. 🔹 Strategic Growth: Scaling our expertise in Oncology and Neurology rare disease while strengthening our legacy in cardiologic, metabolic and venous disease. 🔹 Accelerated Progress: Leveraging regulatory reforms to "deliver the impossible" for patients with urgent clinical needs. A sincere thank you to the Executive Committee for their guidance, to the committed APAC regional team and to our local teams for their unwavering passion. Together, we are turning scientific excellence into hope. Brad Lloyd Claudine Olivier Gilles RENACCO Manuel Ruiz Ruby Han Dong‘e ZHAO Shanshan DU Ming Liu Rebecca Xu Martin Brauer Marcia Matos Xue WANG Cynthia Xin Wang 冯蕾Bing HAN Na LI Ruize M. 创新是施维雅在中国未来发展的驱动力。 我们正处于一个充满前所未有机遇的时代，让我们能够为最需要帮助的患者带来改变生命的突破性疗法。   本周早些时候，施维雅中国有幸迎来了施维雅集团总裁Olivier Laureau先生及执行委员会全体成员的到访。我们共同展开了深入的战略对话，聚焦于通过突破性创新药物和战略合作伙伴关系，重塑医疗健康格局，以永久满足患者的医疗需求。 此次到访的核心包括： 🔹 中国是全球创新的核心引擎：重申中国是集团2030战略目标的重要支柱 🔹战略性增长：提升我们在肿瘤学和神经学罕见病领域的专业水平，同时巩固在心血管、代谢及静脉疾病领域的传统优势。 🔹加速推进：借助监管改革，为具有迫切临床需求的患者“实现不可能”。 衷心感谢执行委员会的指导，感谢敬业的亚太团队以及中国团队成员始终如一的热情。携手并肩，让我们将科学卓越转化为希望。 #Servier #Innovation #Healthcare #Oncology #Leadership #GlobalHealth

👏✨ Today, we celebrate World Adherence Day!   At #ServierChina, we are proud to join the global community in raising awareness about the critical importance of treatment adherence for better health outcomes.   💊 Non-adherence to medication, lifestyle recommendations, and healthcare plans remains a significant challenge, often leading to preventable hospitalizations and worsened health conditions.   We believe that therapeutic adherence demands more than just patient commitment—it is a shared responsibility. It requires collective efforts across research, policy, healthcare delivery, and community stakeholders to identify and break down the barriers that prevent patients from following their care plans.   Let's take action to empower patients to #StayOnTrack from day one. Through small, consistent steps, we can help patients unlock the full potential of their treatments and safeguard their most precious life moments.   👏✨ 今天，我们共同庆祝世界依从性日！   施维雅中国很荣幸与全球各界伙伴携手，共同提升公众对治疗依从性对改善健康结果至关重要性的认识。   💊未能遵从用药、生活方式建议及医疗计划仍是重大挑战，往往导致本可避免的住院治疗及健康状况恶化。   我们相信，治疗依从性不仅需要患者的承诺，更是一项共同责任。这需要科研、政策制定、医疗服务提供及社区利益相关方通力合作，共同识别并解决依从性提升难题。   让我们共同行动，帮助患者从治疗第一天起就坚持规范治疗。通过持续不断的点滴努力，我们可以帮助患者充分发挥治疗的全部潜力，守护他们生命中最珍贵的时刻。   #WorldAdherenceDay #DontMissAMoment #ServierChina #WeAreServier #MovedByYou #PatientCentricity #Healthcare

From Strategy to Reality: Digital Transformation at #ServierChina 🌏🚀 Digital is no longer just a goal; it is an integral part of how we operate in China. We are moving beyond strategic planning to implement tangible, on-the-ground practices that integrate #AI, #data, and #digital technology into our DNA. What makes this shift successful? Our people. 🤝💡 From our passionate Digital Ambassadors to colleagues across every function, the collective engagement of our team is turning our digital vision into real-world business impact. We are reshaping our daily ways of working, empowering everyone to innovate and build the future of healthcare together. 🏥 We are well on our way to becoming a "best-in-class Digital Performer" — working smarter and moving faster, ultimately for the benefit of our patients. #DigitalTransformation #Innovation #HealthTech #Servier #FutureOfHealthcare   从战略走向实践：#施维雅中国 开启数字化之旅 🌏🚀 数字化已不再仅仅是一个目标，它已成为我们在中国运营中不可或缺的一部分。我们不仅制定战略规划，更是将 #人工智能 、#数据 和 #数字化 技术融入我们的每日工作，落实到具体的、实地的实践中。 这一转型的秘诀是什么？是我们的员工。🤝💡 从充满激情的数字化大使 (Digital Ambassadors) 到各个职能部门的同事，正是团队的集体参与，将我们的数字化愿景转化为了现实业务的影响力。我们正在重塑日常工作方式，赋能每一个人共同创新，携手构建医疗健康事业的未来。🏥 我们正稳步迈向成为“卓越数字化践行者”的目标——更智慧地工作，更快速地行动，最终造福广大患者。

Every rare disease is unique, and neurological disorders bring a particularly complex set of challenges for patients and their families.   Today, #ServierChina established a meaningful partnership with the Chinese Organization for Rare Disorders (CORD), bringing both teams together for in-depth dialogue focused on the unmet medical needs of patients living with rare neurological conditions in China. We didn’t just discuss data; we discussed lives. By mapping the real-world hurdles faced by families in China, we are gaining a deeper understanding of the "quiet strength" it takes to face a rare condition every single day. Key takeaways from our exchange:  📌 Beyond Data: While statistics define the "what," it is the patient journey that reveals the "why." 📌 Resilience in Action: We are mapping the emotional and physical hurdles families face, witnessing the incredible courage required to navigate the unknown daily. 📌 Global Synergy: By leveraging our global R&D and clinical expertise, we are ready to translate these insights into concrete medical progress. Our Commitment:  ✅ Deepening our understanding of the Chinese patient journey.  ✅ Partnering with stakeholders to uncover new opportunities for care.  ✅ Utilizing our global clinical expertise to provide real-world solutions. The road ahead is long, but the opportunity to transform lives is what drives us. Grateful for the collaboration of our Global and APAC colleagues who joined us for this milestone. Let’s continue to walk this path together. 🤝 Gilles RENACCO, Javier Avendaño, MD, Nitza Thomasson, Samuele Doratori, Thibault PEUDON, Géraldine Veyrard, Marcia Matos, Manuel Ruiz, Cynthia Xin Wang, donge Zhao, Lianyu Guo, Rebecca Xu, Ruby Han, Shanshan DU, Vivian WANG, Wenjing GAN, Xue WANG, Yinna Wang, Yu WEN 每一种罕见病都是独特的，而神经系统疾病给患者及其家庭带来了尤为复杂的挑战。 今天，#施维雅中国 与蔻德罕见病中心(CORD) 建立了具有里程碑意义的伙伴关系。双方团队齐聚一堂，就中国神经系统罕见病患者尚未被满足的医疗需求进行了深度对话。我们讨论的不只是数据，更是生命。通过梳理中国罕见病家庭面临的现实障碍，我们对每一天对抗罕见病所需的“无声力量”有了更深刻的理解。 此次交流的核心要点： 📌 超越数据： 数据定义了“是什么”，而患者的真实旅程才揭示了“为什么”。 📌 韧性的力量： 我们正在梳理这些家庭面临的情感和身体障碍，亲眼见证了在每天面对未知挑战时所展现的非凡勇气。 📌 全球协同： 凭借我们全球的研发实力和临床专业知识，我们已准备好将这些洞察转化为具体的医疗进展。   我们的承诺： ✅ 深化对中国患者旅程的理解。 ✅ 与利益相关方合作，挖掘新的治疗与护理机会。 ✅ 利用我们的全球临床专业知识，提供切实可行的解决方案。   前路漫漫，但能够改变生命的机会正是驱动我们前行的动力。 衷心感谢参与这一里程碑时刻的全球及亚太区同事。让我们继续并肩同行。🤝 #Neuroscience #RareDiseases #PatientVoice #ServierChina #HealthEquity

🌟 Honoring a Legacy, Embracing the Future 🌟   The legacy of Dr. Bussière continues to inspire us, embodying a spirit of compassion and dedication in all our efforts.   We are proud that our Group President and CEO, Mr. Olivier Laureau, joined the official delegation for the recent visit of the French President to China. This visit was more than just a diplomatic mission; it was a heartfelt commitment to innovation and long-term collaboration. A highlight was the visit to the Bussière Garden in Beijing—a beautiful symbol of our dedication to healthcare and the strong bonds we share.   Mr. Laureau’s presence serves as a powerful reminder of the deep connection between France and China in advancing health and well-being. Since 1979, Servier has been dedicated to bringing innovative therapies to patients, establishing a robust foundation in research, development, and local manufacturing. Together, we are breaking barriers in oncology, ensuring that transformative treatments reach those who need them most.   With biopharmaceuticals identified as a key area for collaboration, we feel a renewed sense of purpose. As we look ahead, our journey of Franco-Chinese cooperation in healthcare aims to bring hope and healing to patients both in China and around the world. Together, we are writing a new chapter filled with promise and possibility!   💪✨ Let’s continue to make a difference!   🌟 传承经典，拥抱未来🌟    贝熙业医生的感人事迹持续激励着我们，让我们在工作中保持仁心与奉献精神。   我们为集团总裁兼首席执行官Olivier Laureau先生随法国总统访华而感到无比自豪。此行不仅是一次外交活动，更是对我们共同致力于创新与长期合作的有力肯定。Laureau先生还有一段意义非凡的驻足——参访北京贝家花园，这里象征着中法两国对医疗事业的奉献精神以及彼此间的情谊纽带。   Laureau先生的到访有力地印证了中法在促进健康福祉领域的深厚纽带。自1979年进入中国以来，施维雅始终致力于为患者提供创新疗法，在研发与本土化生产领域奠定了坚实基础。如今我们正在肿瘤领域不断实现突破，让变革性的疗法惠及最需要的患者。   随着生物医药被确立为中法合作的重点领域，我们更感使命在肩。展望未来，中法医疗合作之旅将为中国乃至全球患者带来希望与治愈。携手向前，我们正在谱写充满无限可能与光明前景的新篇章！   💪✨ 让我们继续创造改变！

🌟 We are excited to share a significant honor for Servier China: we have been honored with the Breakthrough Innovation - Early Pilot Implementation Award at the 4th Boao International Conference on Real-World Studies of Medical Products and the 1st Global Innovative Pharmaceutical and Medical Device Expo! This recognition reflects our unwavering commitment to pioneering innovative targeted therapies that truly make a difference in patients' lives. Our participation in this prestigious event garnered significant attention from regulatory authorities, hospital experts, and industry peers, reinforcing our position as leaders in advancing personalized medicine. In addition to the Breakthrough Innovation Award, we were also proud recipients of the Best Collaboration Award. These accolades highlight the power of our cross-functional teamwork across research, medical affairs, regulatory affairs, and market access. It is this seamless collaboration that enables us to bring transformative therapies to the market and address the evolving needs of patients. Thank you to everyone who has been part of this journey. Together, we are making strides toward a healthier future! Mehdi Kertous Xiaowei WANG Qiaohui KANG 冯蕾 Ruby Han #ServierChina #Innovation #PersonalizedMedicine #HealthcareExcellence #Awards #Collaboration 🌟 我们很高兴地分享 Servier 中国的重要荣誉：我们在第四届博鳌国际医药产品真实世界研究大会暨首届全球创新药品与医疗器械博览会上荣获 突破性创新 - 早期试点实施奖！ 这一荣誉体现了我们对开发创新靶向疗法的坚定承诺，这些疗法真正能够改变患者的生活。我们在这一盛会上的参与得到了监管机构、医院专家和行业同仁的广泛关注，进一步巩固了我们在推动个性化医疗方面的领导地位。 除了突破性创新奖，我们还荣获了 最佳合作奖。这些奖项彰显了我们在研究、医学事务、监管事务和市场准入等领域的跨职能团队合作的力量。正是这种无缝的协作，使我们能够将变革性疗法推向市场，满足患者不断变化的需求。 感谢每一位参与这段旅程的人。让我们共同努力，迈向更健康的未来！ #施维雅中国 #创新 #个性化医疗 #医疗卓越 #奖项 #合作

With the goals and ambitions in sync, we're ready to embrace the year ahead with full momentum!   Once a year, our annual company conference always fills our hearts with anticipation and excitement. It is not just to plan for the future, but to celebrate the spirit of unity and collaboration that defines us.   This year, we gathered around a shared vision and a winning mindset. It was a fantastic opportunity to connect colleagues spread out in 27 provinces as one team, welcome new colleagues, align on key priorities for the year ahead, and build momentum to achieve them together. Most importantly, we focused on how we can work together to make the greatest impact for the patients we serve.   Our culture, rooted in our values, vocation, and collaborative spirit, drives us toward excellence and innovation every day. Culture Up serves as a catalyst for positive change, creating space to challenge status quo and embrace new ways of collaborating as we confidently move toward our #Servier2030 vision.   We honored our colleagues who have dedicated between 5 to 25 years to Servier. Their unwavering commitment is truly inspiring and exemplifies our dedication to excellence. Their stories remind us of the power of perseverance and the beauty of dedication.   Our collaboration is showcased by our colleagues in both China and HQ working hand in hand to serve Chinese patients. A heartfelt thank you to our regional and global leadership for their unwavering support and guidance. Your presence inspires us deeply.   Looking ahead, we recognize the vast unmet medical needs in China. United, we are committed to making an impact on the lives of the patients we serve. Together, we have the power to change lives and strive for excellence! 施维雅中国团队近日齐聚一堂，共赴年度公司大会——这场会议让我们心怀期待与激动。 每年此时，我们不仅为规划未来而聚首，更为表彰我们的团结协作精神。 今年，我们在共同愿景与致胜思维的指引下凝心聚力。此次会议不仅让地处27个省的同事聚集一堂紧密联结，欢迎新成员加入，明确来年核心目标，并共同积蓄实现目标的势能。最重要的是，我们聚焦如何携手为患者创造最大价值。 植根于价值观、信念与协作精神的企业文化，每日驱动我们追求卓越与创新。Culture Up正成为积极变革的催化剂，为我们创造空间挑战现有模式，拥抱全新协作方式，坚定迈向2030愿景。 同时，我们表彰了服务公司5年至25年的同事。他们坚定不移的奉献精神令人动容，彰显了我们追求卓越的信念。他们的故事让我们重温坚韧的力量，领略忠诚的美好。   中国团队与总部同仁携手为中国患者提供服务，充分调动全球资源，正是我们协作精神的生动体现。这种团队协作精神是施维雅中国成功与光明未来的基石。   展望未来，我们深知中国存在着巨大的未满足医疗需求。团结一致，我们致力于为患者生活带来深远改变。携手同行，我们有能力改变生命轨迹，携手追求卓越！   #MovedbyYou #Healthcare #Teamwork #Innovation #Excellence

We are incredibly proud and deeply honored to have been granted the prestigious 施维雅 Group Awards 2025! This remarkable recognition celebrates the dedication, innovation, and teamwork of our extraordinary colleagues. 🏆Winning "The Employee Choice Award" is a profound testament to our unwavering commitment to advancing healthcare and making a real difference in patients' lives. It highlights our heartfelt efforts in bringing groundbreaking oncology treatments to China, ensuring that patients receive the best-in-class possible care. 👏We extend our deepest gratitude to every member of our team for their passion, creativity, and relentless pursuit of excellence. Your contributions are the driving force behind our success and the positive impact we have on the healthcare community. At Servier China, we remain devoted to pushing boundaries and striving for excellence in everything we do. Together, we are shaping a future driven by innovation, guided by purpose, and built on a foundation of collaboration and compassion. Let us continue to advance treatment progress and transform lives through our shared commitment to science and patient care. Manuel Ruiz, Ruby Han, Ruize M., Xiaoling Luo, Ming Liu, WANG Xue, ZHANG Jianmin, ZHANG Bin, Tony LI Chao, 冯蕾 我们为获得2025施维雅集团年度荣誉感到无比自豪和荣幸！这项殊荣彰显了我们杰出员工的奉献精神、创新思维与团队协作。 赢得“员工选择奖”充分印证了我们推动医疗进步、切实改善患者生活的坚定承诺。该奖项凸显了我们为将突破性肿瘤治疗方案引入中国所付出的真诚努力，以确保患者获得同类最优的治疗。 我们要向团队成员致以诚挚谢意，感谢你们满怀热忱、勇于创新以及追求卓越的精神。正是你们的贡献推动着我们的成功，为医疗健康领域带来积极影响。 在施维雅中国，我们始终致力于打破边界，在每个领域追求卓越。我们正携手塑造一个由创新驱动、以使命为指引、立足协作与关怀的未来。 让我们继续秉持对科学和患者关怀的共同承诺，推动治疗领域进步，改变生命轨迹。

At #ServierChina, our unwavering commitment of the social responsibility to empower education and health for children is more than just a mission—it's a heartfelt promise embedded in our culture and legacy. We believe in creating a lasting impact by encouraging employees to participate in meaningful CSR activities that foster positive change. In 2025, with the steadfast support of the Mécénat 施维雅, Servier China is incredibly proud to launch the ✨"Light Up a Star" initiative in collaboration with the Share The Care Volunteer Organization. This initiative is dedicated to supporting the children in Yushu, Qinghai, one of China's most remote and underserved areas. Our employee volunteers will deliver online courses customized to meet the diverse learning needs of these children, including First Aid Knowledge, Medication Usage Basics, History and Geography, Physics, and Astronomy. But our mission doesn't stop there. We are also building shower facilities and donating hygiene kits to keep children warm and healthy.🚿🎒 We are deeply grateful to the Servier China employees who selflessly dedicate their time, share their knowledge, and pour their hearts into making a difference in the lives of those who need it most. Your compassion and commitment are the driving force behind our mission, and we cannot thank you enough for your unwavering support and generosity. 在施维雅中国，我们对儿童教育与健康事业的坚定承诺不仅是使命，更是植根于企业文化与传承的真诚承诺。我们坚信，通过鼓励员工参与具有深远意义的企业社会责任活动，能够推动积极变革并创造持久影响。 在Mécénat Servier Charity Fund的大力支持下，我们携手“有爱有未来”公益组织共同启动“星续温暖 共赴山海——施维雅青海乡村支持项目”。该计划致力于帮扶青海玉树地区的孩子们，他们生活在中国最偏远地区之一。 我们的员工将为孩子们量身定制在线课程，涵盖急救知识、用药基础、历史地理、物理及天文等多元学习需求。但我们的使命不止于此。我们同时修建淋浴设施并捐赠卫生用品包，力所能及的确保孩子们保暖和健康。 我们深深感激施维雅中国的员工，他们无私地奉献时间、分享知识，并倾注心血，改变那些最需要帮助的人的生活。你们的同情心和奉献精神是我们使命的驱动力，我们对你们坚定支持和慷慨付出感到无比的骄傲。 #MecenatServier #EducationForAll #LightUpAStar #WeAreServier #MovedbyYou